Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ · Healthcare
Insight Molecular Diagnostics Inc. Operating Income 2020–2025
Insight Molecular Diagnostics Inc. annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Insight Molecular Diagnostics Inc. operating income for the quarter ending March 31, 2026 was -4.4 M, a 35.09% decrease year-over-year.
- Insight Molecular Diagnostics Inc. operating income for the twelve months ending March 31, 2026 was -32.1 M, a 5.38% decrease year-over-year.
- Insight Molecular Diagnostics Inc. annual operating income for 2025 was -51.1 M, a 16.25% decrease from 2024.
- Insight Molecular Diagnostics Inc. annual operating income for 2024 was -61.0 M, a 142.84% increase from 2023.
- Insight Molecular Diagnostics Inc. annual operating income for 2023 was -25.1 M, a 39.67% increase from 2022.
- Insight Molecular Diagnostics Inc. annual operating income for 2022 was -18.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Insight Molecular Diagnostics Inc. Operating Income — FAQ
Insight Molecular Diagnostics Inc. (IMDX) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Insight Molecular Diagnostics Inc.'s operating income?
Insight Molecular Diagnostics Inc. (IMDX) reported operating income of -$51M for fiscal 2025.
Where can I see IMDX's operating income history?
The chart and table above show Insight Molecular Diagnostics Inc.'s operating income by year and by quarter, including the growth rate.